Barclays raised the firm’s price target on Colgate-Palmolive to $91 from $85 and keeps an Equal Weight rating on the shares. The analyst believes the macro backdrop and/or relative valuations “present a difficult investment landscape” within U.S. consumer staples heading into the Q2 reports. Food valuations appear attractive, though the fundamentals largely do not, the analyst tells investors in a research note. The firm says it “feels difficult to find pockets of meaningful upside potential at either end of the spectrum right now.”
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive price target raised to $104 from $98 at Deutsche Bank
- Colgate-Palmolive price target raised to $110 from $100 at BofA
- Colgate-Palmolive price target raised to $112 from $103 at Citi
- Colgate-Palmolive initiated with an Outperform at Exane BNP Paribas
- Colgate-Palmolive Stock (NYSE:CL): Unjustifiably Expensive in Today’s Market